Back

Symptoms and quality of life in individuals with screen-detected atrial fibrillation: insights from the NORSCREEN trial

29 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: metabolic and mechanistic insights Prevalence and Incidence of Atrial Fibrillation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Miroslav Boskovic

Sorlandet Hospital, Kristiansand (Norway)

6 More presentations in this session

Presentation thumbnail
Sex-specific FIND-AF risk thresholds aligned with CMR-defined atrial cardiomyopathy identify excess cardiovascular risk in heart failure across nationwide primary care data
Doctor K. Kazi (Manchester, GB)
Abstract
Presentation thumbnail
Gut microbiota-derived isovaleric acid alleviates atrial fibrillation by suppressing GSDME-dependent pyroptosis
Doctor N. Ding (Xi'an, CN)
Abstract
Presentation thumbnail
Influence of AF burden on NT-proBNP and left ventricular reverse remodeling in patients with AF and HF: catheter ablation versus pharmacological rhythm control
Doctor B. Orazlyyeva (Ashgabat, TM)
Abstract
Presentation thumbnail
Metabolic improvement without structural reverse remodelling in diabetic atrial fibrillation patients receiving lifestyle modification: A post-hoc analysis of the PRAGUE-25 trial
Doctor J. Mohr (Trinec, CZ)
Abstract
Presentation thumbnail
Association of diabetes, glycemic status and vascular brain lesions in patients with atrial fibrillation
Ms S. Balasundaram (Basel, CH)
Abstract

Access the full session

Session thumbnail
Atrial fibrillation: metabolic and mechanistic insights

The Event

Event poster

ESC Congress 2026

29 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Atrial fibrillation screening: feasible approaches and implementation challenges across Europe
27 August 2021
thumbnail
Congress Presentation
Symptom burden, coagulopathy and heart disease, and quality of life at baseline and after 1-year follow-up following acute SARS-CoV-2 infection in a community medicine setting
28 August 2023
thumbnail
Congress Presentation
Quality of life in patients with atrial fibrillation taking into account the phenotype of heart failure
12 May 2024
thumbnail
Congress Presentation
Quality of life after screening for atrial fibrillation: a substudy from a randomised screening trial
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources